93. Primary biliary cholangitis Clinical trials / Disease details

Clinical trials : 298 / Drugs : 252 - (DrugBank : 59) / Drug target genes : 35 - Drug target pathways : 115

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04522869 (ClinicalTrials.gov)	August 10, 2019	4/9/2019	Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia	Evaluation Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia: A Matched Control Prospective Study	Primary Biliary Cirrhosis	Biological: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation	Vinmec Research Institute of Stem Cell and Gene Technology	Children's Hospital Number 2, Ho Chi Minh City, Vietnam	Recruiting	5 Months	2 Years	All	34	Phase 1/Phase 2	Vietnam
2	NCT01440309 (ClinicalTrials.gov)	November 2011	20/9/2011	Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis	Phase I Clinical Trial, Randomized, Controlled, to Evaluate the Efficacy and Safety of Therapy With Allogenic Mesenchymal Stem Cells From Bone Marrow for Patients With Refractory Primary Biliary Cirrhosis	Primary Biliary Cirrhosis	Biological: Biological: mesenchymal stem cell;Drug: ursodeoxycholic acid	Robert Chunhua Zhao, MD, PhD	Peking Union Medical College Hospital	Recruiting	18 Years	60 Years	Both	20	Phase 1	China